Todd P. Branning

Insider Reports History

Location
Bridgewater, NJ
Signature
/s/ Todd P. Branning
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd P. Branning:

Company Role Class Num Shares Value Price $ Report Date Ownership
NeuBase Therapeutics, Inc. Chief Financial Officer Common stock 84,200 $161,664 $1.92 16 Mar 2023 Direct
NeuBase Therapeutics, Inc. Chief Financial Officer Stock option (right to buy) 200,000 03 Nov 2022 Direct

Insider Reports Filed by Todd P. Branning

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBSE NeuBase Therapeutics, Inc. 16 Mar 2023 1 $0 4 Chief Financial Officer 17 Mar 2023, 16:11
NBSE NeuBase Therapeutics, Inc. 03 Nov 2022 1 $0 4 Chief Financial Officer 04 Nov 2022, 17:00
NBSE NeuBase Therapeutics, Inc. 18 Mar 2022 1 $18,100 4 Chief Financial Officer 21 Mar 2022, 16:06
NBSE NeuBase Therapeutics, Inc. 16 Mar 2022 2 $33,600 4 Chief Financial Officer 18 Mar 2022, 16:11
NBSE NeuBase Therapeutics, Inc. 10 Jan 2022 1 $0 4 Chief Financial Officer 10 Jan 2022, 18:19
NBSE NeuBase Therapeutics, Inc. 10 Jan 2022 0 $0 3 Chief Financial Officer 10 Jan 2022, 18:15